nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Alkylating Activity—Temozolomide—malignant glioma	0.474	0.522	CiPCiCtD
Estramustine—Alkylating Activity—Carmustine—malignant glioma	0.433	0.478	CiPCiCtD
Estramustine—CYP3A4—Temozolomide—malignant glioma	0.0151	1	CbGbCtD
Estramustine—MAP2—telencephalic ventricle—malignant glioma	0.00428	0.122	CbGeAlD
Estramustine—MAP1A—embryo—malignant glioma	0.00223	0.0634	CbGeAlD
Estramustine—MAP1A—brainstem—malignant glioma	0.00204	0.0581	CbGeAlD
Estramustine—MAP1A—retina—malignant glioma	0.00197	0.0561	CbGeAlD
Estramustine—MAP1A—telencephalon—malignant glioma	0.00181	0.0516	CbGeAlD
Estramustine—MAP1A—medulla oblongata—malignant glioma	0.00142	0.0405	CbGeAlD
Estramustine—MAP1A—midbrain—malignant glioma	0.0013	0.0371	CbGeAlD
Estramustine—MAP1A—spinal cord—malignant glioma	0.00127	0.0362	CbGeAlD
Estramustine—MAP2—embryo—malignant glioma	0.00126	0.0361	CbGeAlD
Estramustine—MAP2—brainstem—malignant glioma	0.00116	0.033	CbGeAlD
Estramustine—Myelosuppression—Carmustine—malignant glioma	0.00112	0.0686	CcSEcCtD
Estramustine—MAP2—retina—malignant glioma	0.00112	0.0319	CbGeAlD
Estramustine—Myelosuppression—Temozolomide—malignant glioma	0.00109	0.0663	CcSEcCtD
Estramustine—MAP1A—central nervous system—malignant glioma	0.00103	0.0293	CbGeAlD
Estramustine—MAP2—telencephalon—malignant glioma	0.00103	0.0293	CbGeAlD
Estramustine—MAP1A—cerebellum—malignant glioma	0.00101	0.0287	CbGeAlD
Estramustine—ESR1—blood vessel—malignant glioma	0.000941	0.0268	CbGeAlD
Estramustine—MAP1A—brain—malignant glioma	0.000817	0.0233	CbGeAlD
Estramustine—MAP2—medulla oblongata—malignant glioma	0.000808	0.023	CbGeAlD
Estramustine—Embolism—Temozolomide—malignant glioma	0.000793	0.0484	CcSEcCtD
Estramustine—ESR2—brainstem—malignant glioma	0.000751	0.0214	CbGeAlD
Estramustine—MAP2—midbrain—malignant glioma	0.000739	0.0211	CbGeAlD
Estramustine—MAP2—spinal cord—malignant glioma	0.000721	0.0205	CbGeAlD
Estramustine—ESR2—telencephalon—malignant glioma	0.000667	0.019	CbGeAlD
Estramustine—MAP2—central nervous system—malignant glioma	0.000585	0.0167	CbGeAlD
Estramustine—MAP2—cerebellum—malignant glioma	0.000571	0.0163	CbGeAlD
Estramustine—ESR1—embryo—malignant glioma	0.000561	0.016	CbGeAlD
Estramustine—ESR1—brainstem—malignant glioma	0.000514	0.0147	CbGeAlD
Estramustine—Skin exfoliation—Carmustine—malignant glioma	0.000503	0.0307	CcSEcCtD
Estramustine—Skin exfoliation—Temozolomide—malignant glioma	0.000486	0.0297	CcSEcCtD
Estramustine—Gynaecomastia—Carmustine—malignant glioma	0.000471	0.0288	CcSEcCtD
Estramustine—MAP2—brain—malignant glioma	0.000464	0.0132	CbGeAlD
Estramustine—ESR1—telencephalon—malignant glioma	0.000457	0.013	CbGeAlD
Estramustine—Thrombophlebitis—Carmustine—malignant glioma	0.000442	0.027	CcSEcCtD
Estramustine—Thrombophlebitis—Temozolomide—malignant glioma	0.000427	0.0261	CcSEcCtD
Estramustine—Eye pain—Carmustine—malignant glioma	0.000424	0.0259	CcSEcCtD
Estramustine—Eye pain—Temozolomide—malignant glioma	0.000409	0.025	CcSEcCtD
Estramustine—Hot flush—Temozolomide—malignant glioma	0.000395	0.0241	CcSEcCtD
Estramustine—Menopausal symptoms—Temozolomide—malignant glioma	0.000392	0.0239	CcSEcCtD
Estramustine—Thirst—Temozolomide—malignant glioma	0.000388	0.0237	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000383	0.0233	CcSEcCtD
Estramustine—ESR2—central nervous system—malignant glioma	0.000379	0.0108	CbGeAlD
Estramustine—ABCB1—blood vessel—malignant glioma	0.000372	0.0106	CbGeAlD
Estramustine—ESR2—cerebellum—malignant glioma	0.00037	0.0106	CbGeAlD
Estramustine—Affect lability—Temozolomide—malignant glioma	0.000364	0.0222	CcSEcCtD
Estramustine—Liver function test abnormal—Carmustine—malignant glioma	0.000353	0.0215	CcSEcCtD
Estramustine—Mood swings—Temozolomide—malignant glioma	0.00035	0.0214	CcSEcCtD
Estramustine—Dry skin—Temozolomide—malignant glioma	0.000339	0.0207	CcSEcCtD
Estramustine—Pancytopenia—Carmustine—malignant glioma	0.000314	0.0192	CcSEcCtD
Estramustine—Pancytopenia—Temozolomide—malignant glioma	0.000303	0.0185	CcSEcCtD
Estramustine—ESR2—brain—malignant glioma	0.000301	0.00857	CbGeAlD
Estramustine—Erectile dysfunction—Temozolomide—malignant glioma	0.000294	0.018	CcSEcCtD
Estramustine—Depression—Carmustine—malignant glioma	0.000294	0.0179	CcSEcCtD
Estramustine—Depression—Temozolomide—malignant glioma	0.000284	0.0173	CcSEcCtD
Estramustine—ESR1—central nervous system—malignant glioma	0.00026	0.0074	CbGeAlD
Estramustine—ESR1—cerebellum—malignant glioma	0.000254	0.00723	CbGeAlD
Estramustine—Flushing—Carmustine—malignant glioma	0.000246	0.015	CcSEcCtD
Estramustine—Tinnitus—Temozolomide—malignant glioma	0.000238	0.0145	CcSEcCtD
Estramustine—Flushing—Temozolomide—malignant glioma	0.000237	0.0145	CcSEcCtD
Estramustine—Ethinyl Estradiol—CYP2B6—malignant glioma	0.000236	0.417	CrCbGaD
Estramustine—Alopecia—Carmustine—malignant glioma	0.000234	0.0143	CcSEcCtD
Estramustine—Alopecia—Temozolomide—malignant glioma	0.000226	0.0138	CcSEcCtD
Estramustine—ABCB1—embryo—malignant glioma	0.000222	0.00632	CbGeAlD
Estramustine—Leukopenia—Carmustine—malignant glioma	0.000206	0.0126	CcSEcCtD
Estramustine—ESR1—brain—malignant glioma	0.000206	0.00587	CbGeAlD
Estramustine—Estrone—CYP2B6—malignant glioma	0.000206	0.363	CrCbGaD
Estramustine—Leukopenia—Temozolomide—malignant glioma	0.000199	0.0122	CcSEcCtD
Estramustine—Chest pain—Carmustine—malignant glioma	0.000196	0.012	CcSEcCtD
Estramustine—ABCB1—retina—malignant glioma	0.000196	0.00559	CbGeAlD
Estramustine—Anxiety—Carmustine—malignant glioma	0.000195	0.0119	CcSEcCtD
Estramustine—Anxiety—Temozolomide—malignant glioma	0.000189	0.0115	CcSEcCtD
Estramustine—Oedema—Carmustine—malignant glioma	0.000188	0.0115	CcSEcCtD
Estramustine—Thrombocytopenia—Carmustine—malignant glioma	0.000184	0.0112	CcSEcCtD
Estramustine—Oedema—Temozolomide—malignant glioma	0.000182	0.0111	CcSEcCtD
Estramustine—ABCB1—telencephalon—malignant glioma	0.00018	0.00514	CbGeAlD
Estramustine—Anorexia—Carmustine—malignant glioma	0.000179	0.0109	CcSEcCtD
Estramustine—Thrombocytopenia—Temozolomide—malignant glioma	0.000178	0.0109	CcSEcCtD
Estramustine—Anorexia—Temozolomide—malignant glioma	0.000173	0.0106	CcSEcCtD
Estramustine—Insomnia—Carmustine—malignant glioma	0.00017	0.0104	CcSEcCtD
Estramustine—Dyspnoea—Carmustine—malignant glioma	0.000168	0.0102	CcSEcCtD
Estramustine—Insomnia—Temozolomide—malignant glioma	0.000164	0.01	CcSEcCtD
Estramustine—Decreased appetite—Carmustine—malignant glioma	0.000163	0.00997	CcSEcCtD
Estramustine—Dyspnoea—Temozolomide—malignant glioma	0.000162	0.00988	CcSEcCtD
Estramustine—Decreased appetite—Temozolomide—malignant glioma	0.000158	0.00964	CcSEcCtD
Estramustine—CYP3A4—central nervous system—malignant glioma	0.000145	0.00413	CbGeAlD
Estramustine—ABCB1—medulla oblongata—malignant glioma	0.000142	0.00404	CbGeAlD
Estramustine—ABCB1—midbrain—malignant glioma	0.000129	0.00369	CbGeAlD
Estramustine—Diarrhoea—Carmustine—malignant glioma	0.000129	0.00785	CcSEcCtD
Estramustine—Pruritus—Temozolomide—malignant glioma	0.000129	0.00784	CcSEcCtD
Estramustine—ABCB1—spinal cord—malignant glioma	0.000126	0.0036	CbGeAlD
Estramustine—Testosterone—CYP2B6—malignant glioma	0.000125	0.221	CrCbGaD
Estramustine—Diarrhoea—Temozolomide—malignant glioma	0.000124	0.00758	CcSEcCtD
Estramustine—Vomiting—Carmustine—malignant glioma	0.00012	0.00729	CcSEcCtD
Estramustine—Rash—Carmustine—malignant glioma	0.000119	0.00723	CcSEcCtD
Estramustine—Dermatitis—Carmustine—malignant glioma	0.000118	0.00723	CcSEcCtD
Estramustine—Headache—Carmustine—malignant glioma	0.000118	0.00719	CcSEcCtD
Estramustine—Vomiting—Temozolomide—malignant glioma	0.000116	0.00705	CcSEcCtD
Estramustine—Rash—Temozolomide—malignant glioma	0.000115	0.00699	CcSEcCtD
Estramustine—Dermatitis—Temozolomide—malignant glioma	0.000114	0.00698	CcSEcCtD
Estramustine—Headache—Temozolomide—malignant glioma	0.000114	0.00694	CcSEcCtD
Estramustine—Nausea—Carmustine—malignant glioma	0.000112	0.00681	CcSEcCtD
Estramustine—Nausea—Temozolomide—malignant glioma	0.000108	0.00658	CcSEcCtD
Estramustine—ABCB1—central nervous system—malignant glioma	0.000102	0.00292	CbGeAlD
Estramustine—ABCB1—cerebellum—malignant glioma	0.0001	0.00286	CbGeAlD
Estramustine—ABCB1—brain—malignant glioma	8.14e-05	0.00232	CbGeAlD
Estramustine—ABCB1—Allograft Rejection—CD80—malignant glioma	2.98e-05	0.00114	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	2.96e-05	0.00113	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.96e-05	0.00113	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CD—malignant glioma	2.93e-05	0.00112	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	2.92e-05	0.00112	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	2.91e-05	0.00111	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	2.9e-05	0.00111	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	2.86e-05	0.00109	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.82e-05	0.00108	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—FGF2—malignant glioma	2.8e-05	0.00107	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—malignant glioma	2.8e-05	0.00107	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.79e-05	0.00107	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NOTCH1—malignant glioma	2.79e-05	0.00107	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	2.77e-05	0.00106	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	2.74e-05	0.00105	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	2.67e-05	0.00102	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	2.65e-05	0.00101	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—PPARG—malignant glioma	2.64e-05	0.00101	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	2.63e-05	0.00101	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MDM2—malignant glioma	2.62e-05	0.001	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—RAF1—malignant glioma	2.61e-05	0.000998	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB2—malignant glioma	2.58e-05	0.000988	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—H3F3A—malignant glioma	2.58e-05	0.000986	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	2.57e-05	0.000982	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.57e-05	0.000982	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CB—malignant glioma	2.55e-05	0.000975	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH3—malignant glioma	2.54e-05	0.00097	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	2.53e-05	0.000969	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.48e-05	0.00095	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH3—malignant glioma	2.42e-05	0.000926	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—AKT1—malignant glioma	2.42e-05	0.000924	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LATS1—malignant glioma	2.41e-05	0.00092	CbGpPWpGaD
Estramustine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	2.4e-05	0.000916	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RTEL1—malignant glioma	2.36e-05	0.000903	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	2.36e-05	0.000901	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IFNG—malignant glioma	2.35e-05	0.0009	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	2.33e-05	0.000892	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	2.32e-05	0.000886	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH2—malignant glioma	2.27e-05	0.00087	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	2.26e-05	0.000864	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	2.25e-05	0.000862	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—AKT1—malignant glioma	2.23e-05	0.000854	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	2.22e-05	0.00085	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.22e-05	0.000847	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	2.21e-05	0.000847	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PTEN—malignant glioma	2.2e-05	0.000842	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—malignant glioma	2.19e-05	0.000837	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.18e-05	0.000835	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.18e-05	0.000832	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH2—malignant glioma	2.17e-05	0.00083	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.15e-05	0.000823	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.1e-05	0.000805	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	2.1e-05	0.000803	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	2.1e-05	0.000803	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL1B—malignant glioma	2.1e-05	0.000803	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.1e-05	0.000802	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—malignant glioma	2.09e-05	0.000801	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL2—malignant glioma	2.09e-05	0.0008	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	2.08e-05	0.000796	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	2.08e-05	0.000794	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	2.05e-05	0.000785	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	2e-05	0.000765	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CDKN2B—malignant glioma	1.96e-05	0.000747	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.95e-05	0.000747	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	1.95e-05	0.000744	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	1.89e-05	0.000723	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CDKN2B—malignant glioma	1.87e-05	0.000714	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NCOR1—malignant glioma	1.85e-05	0.000709	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MYC—malignant glioma	1.84e-05	0.000704	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	1.84e-05	0.000702	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	1.8e-05	0.000688	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—malignant glioma	1.79e-05	0.000685	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—malignant glioma	1.78e-05	0.000679	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NCOR1—malignant glioma	1.77e-05	0.000677	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—DNMT3B—malignant glioma	1.73e-05	0.000663	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	1.7e-05	0.00065	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—KRAS—malignant glioma	1.69e-05	0.000647	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	1.69e-05	0.000646	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HIST1H3B—malignant glioma	1.68e-05	0.000644	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	1.66e-05	0.000634	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MDK—malignant glioma	1.63e-05	0.000621	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—PIK3CA—malignant glioma	1.55e-05	0.000594	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DTX1—malignant glioma	1.55e-05	0.000593	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.53e-05	0.000583	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—malignant glioma	1.52e-05	0.000582	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	1.51e-05	0.000579	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—malignant glioma	1.51e-05	0.000578	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—MYC—malignant glioma	1.5e-05	0.000574	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.49e-05	0.00057	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	1.47e-05	0.000561	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RTEL1—malignant glioma	1.46e-05	0.000557	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	1.45e-05	0.000554	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	1.44e-05	0.00055	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.42e-05	0.000543	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	1.42e-05	0.000543	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.41e-05	0.000539	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH1—malignant glioma	1.41e-05	0.000538	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—COX8A—malignant glioma	1.36e-05	0.000519	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH1—malignant glioma	1.34e-05	0.000514	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—PPARG—malignant glioma	1.33e-05	0.000508	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	1.31e-05	0.000501	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—H3F3A—malignant glioma	1.3e-05	0.000497	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.29e-05	0.000495	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	1.28e-05	0.000488	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—AKT1—malignant glioma	1.27e-05	0.000485	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—PPARG—malignant glioma	1.27e-05	0.000485	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.25e-05	0.000479	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	1.23e-05	0.000472	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SUFU—malignant glioma	1.23e-05	0.000471	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH3—malignant glioma	1.22e-05	0.000467	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HEY2—malignant glioma	1.22e-05	0.000465	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—GFAP—malignant glioma	1.19e-05	0.000454	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	1.17e-05	0.000448	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	1.16e-05	0.000442	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ASMT—malignant glioma	1.15e-05	0.000441	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	1.15e-05	0.000441	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	1.15e-05	0.00044	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SPHK1—malignant glioma	1.15e-05	0.00044	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	1.14e-05	0.000435	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HEY1—malignant glioma	1.13e-05	0.000431	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CCR4—malignant glioma	1.13e-05	0.000431	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	1.11e-05	0.000426	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH2—malignant glioma	1.1e-05	0.000419	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIST1H3B—malignant glioma	1.09e-05	0.000418	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BCAN—malignant glioma	1.09e-05	0.000415	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	1.06e-05	0.000405	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.06e-05	0.000404	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	1.03e-05	0.000395	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	1.01e-05	0.000386	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JAG2—malignant glioma	9.99e-06	0.000382	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	9.71e-06	0.000371	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CDKN2B—malignant glioma	9.41e-06	0.00036	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NCOR1—malignant glioma	8.93e-06	0.000341	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	8.77e-06	0.000335	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—IDH2—malignant glioma	8.75e-06	0.000334	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—H3F3A—malignant glioma	8.46e-06	0.000323	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCR3—malignant glioma	8.37e-06	0.00032	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—COX8A—malignant glioma	8.36e-06	0.00032	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP2B6—malignant glioma	8.22e-06	0.000314	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK2—malignant glioma	8.15e-06	0.000311	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—YWHAE—malignant glioma	8.15e-06	0.000311	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FLT1—malignant glioma	8.11e-06	0.00031	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—DUSP6—malignant glioma	8.08e-06	0.000309	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	8.07e-06	0.000309	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—JAG1—malignant glioma	7.97e-06	0.000305	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH3—malignant glioma	7.94e-06	0.000304	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.89e-06	0.000302	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FBXW7—malignant glioma	7.81e-06	0.000299	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BDKRB2—malignant glioma	7.66e-06	0.000293	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—MYC—malignant glioma	7.58e-06	0.00029	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—IDH1—malignant glioma	7.52e-06	0.000288	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	7.52e-06	0.000287	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	7.46e-06	0.000285	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SPHK1—malignant glioma	7.28e-06	0.000278	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—MYC—malignant glioma	7.23e-06	0.000277	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP2C18—malignant glioma	7.13e-06	0.000273	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH2—malignant glioma	7.12e-06	0.000272	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ASMT—malignant glioma	7.11e-06	0.000272	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KNG1—malignant glioma	6.97e-06	0.000266	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.85e-06	0.000262	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH1—malignant glioma	6.78e-06	0.000259	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BCAN—malignant glioma	6.69e-06	0.000256	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NTRK1—malignant glioma	6.64e-06	0.000254	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	6.63e-06	0.000253	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—PPARG—malignant glioma	6.4e-06	0.000245	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP3—malignant glioma	6.17e-06	0.000236	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CDKN2B—malignant glioma	6.12e-06	0.000234	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTK2—malignant glioma	5.94e-06	0.000227	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HES1—malignant glioma	5.84e-06	0.000223	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NCOR1—malignant glioma	5.8e-06	0.000222	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—malignant glioma	5.77e-06	0.00022	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.6e-06	0.000214	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PDGFRA—malignant glioma	5.56e-06	0.000213	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS1—malignant glioma	5.4e-06	0.000207	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SPP1—malignant glioma	5.4e-06	0.000206	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—IDH2—malignant glioma	5.39e-06	0.000206	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—malignant glioma	5.12e-06	0.000196	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP2B6—malignant glioma	5.07e-06	0.000194	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—BCHE—malignant glioma	5.02e-06	0.000192	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—AKT1—malignant glioma	5.02e-06	0.000192	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PDGFB—malignant glioma	4.99e-06	0.000191	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR1—malignant glioma	4.97e-06	0.00019	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—SLC5A5—malignant glioma	4.96e-06	0.00019	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HIF1A—malignant glioma	4.89e-06	0.000187	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CAV1—malignant glioma	4.73e-06	0.000181	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KDR—malignant glioma	4.68e-06	0.000179	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—IDH1—malignant glioma	4.63e-06	0.000177	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.57e-06	0.000175	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FN1—malignant glioma	4.5e-06	0.000172	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—F2—malignant glioma	4.5e-06	0.000172	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SPHK1—malignant glioma	4.48e-06	0.000171	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BAD—malignant glioma	4.45e-06	0.00017	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH1—malignant glioma	4.41e-06	0.000169	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.39e-06	0.000168	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CD80—malignant glioma	4.32e-06	0.000165	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CG—malignant glioma	4.31e-06	0.000165	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—APC—malignant glioma	4.31e-06	0.000165	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGF—malignant glioma	4.26e-06	0.000163	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTPN11—malignant glioma	4.23e-06	0.000162	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—BRAF—malignant glioma	4.05e-06	0.000155	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTP1—malignant glioma	4e-06	0.000153	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT2—malignant glioma	3.94e-06	0.000151	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAT—malignant glioma	3.89e-06	0.000149	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CD—malignant glioma	3.79e-06	0.000145	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NCOR1—malignant glioma	3.67e-06	0.00014	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—MYC—malignant glioma	3.65e-06	0.000139	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGF2—malignant glioma	3.63e-06	0.000139	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—malignant glioma	3.55e-06	0.000136	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MDM2—malignant glioma	3.39e-06	0.00013	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAF1—malignant glioma	3.38e-06	0.000129	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB2—malignant glioma	3.35e-06	0.000128	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS1—malignant glioma	3.33e-06	0.000127	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CB—malignant glioma	3.3e-06	0.000126	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—malignant glioma	3.17e-06	0.000121	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—BCHE—malignant glioma	3.1e-06	0.000118	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.06e-06	0.000117	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—malignant glioma	3.04e-06	0.000116	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL2—malignant glioma	3.03e-06	0.000116	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CAV1—malignant glioma	2.99e-06	0.000114	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—malignant glioma	2.87e-06	0.00011	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PTEN—malignant glioma	2.85e-06	0.000109	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CG—malignant glioma	2.73e-06	0.000104	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PPARG—malignant glioma	2.63e-06	0.000101	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—malignant glioma	2.58e-06	9.85e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—malignant glioma	2.55e-06	9.76e-05	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—AKT1—malignant glioma	2.53e-06	9.67e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTP1—malignant glioma	2.46e-06	9.41e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CD—malignant glioma	2.4e-06	9.17e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAT—malignant glioma	2.4e-06	9.16e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MYC—malignant glioma	2.37e-06	9.07e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—malignant glioma	2.32e-06	8.87e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NCOR1—malignant glioma	2.26e-06	8.65e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KRAS—malignant glioma	2.19e-06	8.38e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CB—malignant glioma	2.09e-06	7.99e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTGS2—malignant glioma	2.07e-06	7.92e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PIK3CA—malignant glioma	2.01e-06	7.7e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—malignant glioma	1.95e-06	7.45e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CAV1—malignant glioma	1.84e-06	7.05e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PTEN—malignant glioma	1.81e-06	6.9e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.68e-06	6.42e-05	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKT1—malignant glioma	1.64e-06	6.29e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PPARG—malignant glioma	1.62e-06	6.2e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.48e-06	5.65e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.29e-06	4.92e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.28e-06	4.88e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.27e-06	4.87e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PTEN—malignant glioma	1.11e-06	4.25e-05	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—AKT1—malignant glioma	1.04e-06	3.98e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.85e-07	3e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—AKT1—malignant glioma	6.41e-07	2.45e-05	CbGpPWpGaD
